- Exchange: NYSE MKT LLC
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Actinium Pharmaceuticals Inc+ Add to Watchlist
ATNM:US5.3900 USD 0.2500 4.43%
As of 20:04:05 ET on 01/30/2015.
Company Profile for Actinium Pharmaceuticals Inc (ATNM)
Actinium Pharmaceuticals Inc. operates as a biopharmaceutical company. The Company develops alpha particle immunotherapeutics and other radiopharmaceuticals for select applications.
Actinium Pharmaceuticals Inc
Key Executives for Actinium Pharmaceuticals Inc (ATNM)
|Sandesh SethChairman||Kaushik J DavePresident/CEO/Interim CFO|
|Dragan CicicCOO/Chief Medical Officer|